Mankind Pharma rallies 32% on day 1

May 10, 2023

At Tuesday’s closing price, Mankind Pharma was valued at a price-to-earnings ratio of 43 times its FY22 earnings. Mankind is now India’s fifth largest pharma company by market value of ₹57,046 crore. Sun Pharma, Divi’s Lab, Dr. Reddy’s Lab, and Cipla are currently valued between ₹75,284 crore and ₹2.31 lakh crore.

More To Explore

Rupee gains 24 paise to 85.77 on weak dollar index

The currency strengthened to 85.59/$1 levels during the day, before losing some ground due to importer hedging demand, while likely intervention by theReaerve Bank of

April 16, 2025

PwC pegs IndusInd Bank’s losses at Rs 1,979 crore

Based on the PwC report submitted on Tuesday, IndusInd Bank said it has assessed an adverse impact (on a post-tax basis) of 2.27% to the

April 16, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003